FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
FLUARIX QUADRIVALENT is approved for use in persons 3 years of age and older
ADACEL vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in people 11 through 64 years of age
ZOSTAVAX* is supplied as follows: (1) a package of 10 single-dose vials of lyophilized vaccine, NDC 0006-4963-41 (package A); and (2) a separate package of 10 vials of diluent (package B)
ZOSTAVAX* is stored frozen and should be reconstituted immediately upon removal from the freezer
The diluent should be stored separately at room temperature (20 to 25 degrees celcius, 68 to 77 degrees fahrenheit), or in the refrigerator (2 to 8 degrees celcius, 36 to 46 degrees fahrenheit)